Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis
article
OA: bronze
CC0
⤵ 109 in-corpus citations
AI-generated summary
Plasma miR-17-5p, miR-20a, and miR-22 were significantly down-regulated in women with endometriosis compared to controls, suggesting potential as non-invasive biomarkers.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY QUESTION: Can plasma microRNAs be used as a non-invasive diagnostic test for the detection of endometriosis? SUMMARY ANSWER: Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis compared with those without endometriosis in mainland China. WHAT IS KNOWN ALREADY: There is currently a pressing need to develop a non-invasive diagnostic test for endometriosis. Altered circulating microRNA profiles have already been linked to various disease states. STUDY DESIGN, SIZE, AND DURATION: This was a prospective laboratory study in a tertiary-referral university hospital in Beijing, PR China, between January 2012 and May 2012. Twenty-three women with histologically proven endometriosis and 23 endometriosis-free controls were enrolled in this study. PARTICIPANTS/MATERIALS, SETTING, AND METHODS: Laparoscopic inspection of the abdominopelvic cavity was performed for each patient, and peripheral blood samples were collected before laparoscopy. Microarray-based microRNA expression profiling was used to identify differentially expressed microRNAs in plasma samples between women with and without endometriosis, and quantification of selected microRNAs was performed using quantitative RT-PCR. MAIN RESULTS AND THE ROLE OF CHANCE: Twenty-seven microRNAs were differentially expressed between women with and without endometriosis, of which six microRNAs (miR-15b-5p, miR-17-5p, miR-20a, miR-21, miR-22 and miR-26a) were selected for validation. MiR-17-5p, miR-20a and miR-22 were significantly down-regulated in women with endometriosis compared with controls (P = 0.011, 0.0020 and 0.0002, respectively), yielding an area under the receiver operator characteristics curve of 0.74 [95% confidence interval (CI): 0.58-0.90], 0.79 (95% CI: 0.65-0.93) and 0.85 (95% CI: 0.71-0.98) in discriminating endometriosis from controls, respectively. LIMITATIONS AND REASONS FOR CAUTION: Our sample size was small and all cases were rAFS stage III-IV, which may limit generalization of plasma microRNAs for early diagnosis of endometriosis. Moreover, only six microRNAs were selected for validation. WIDER IMPLICATIONS OF THE FINDINGS: Plasma microRNAs provide a promising opportunity for detection of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (64)
- Coexistence of endometriosis in women with symptomatic leiomyomas via openalex
- Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis via openalex
- Differential Expression of MicroRNAs between Eutopic and Ectopic Endometrium in Ovarian Endometriosis via openalex
- Do symptomatic endometriosis and uterine fibroids appear together? via openalex
- Endometriosis via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Functional MicroRNA Involved in Endometriosis via openalex
- Hypoxia-Induced MicroRNA-20a Expression Increases ERK Phosphorylation and Angiogenic Gene Expression in Endometriotic Stromal Cells via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis via openalex
- MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis via openalex
- MicroRNA-Regulated Pathways Associated with Endometriosis via openalex
- microRNAs expression in endometriosis and their relation to angiogenic factors via openalex
- MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKK /NF- B pathway and reduced interleukin-8 expression via openalex
- Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis via openalex
- Peripheral biomarkers of endometriosis: a systematic review via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The Expression and Ovarian Steroid Regulation of Endometrial Micro-RNAs via openalex
- The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression via openalex
- The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
- The role of microRNAs in endometriosis and associated reproductive conditions via openalex
- Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis via openalex
- W2097713515 via openalex
- W2107277218 via openalex
- W2108836814 via openalex
- W2111848990 via openalex
- W2113810141 via openalex
- W2113899452 via openalex
- W2115093090 via openalex
- W18374401 via openalex
- W2120071142 via openalex
- W2125052189 via openalex
- W2135810600 via openalex
- W2139528114 via openalex
- W2146543607 via openalex
- W2161068194 via openalex
- W2163169629 via openalex
- W2166050085 via openalex
- W2170070360 via openalex
- W2171296186 via openalex
- W2119604948 via openalex
- W1963853602 via openalex
- W1991084052 via openalex
- W2005479935 via openalex
- W2006760151 via openalex
- W2007173417 via openalex
- W2014946489 via openalex
- W2017426710 via openalex
- W2025449301 via openalex
- W2027744584 via openalex
- W2032696674 via openalex
- W2037054089 via openalex
- W2047119105 via openalex
- W2050245631 via openalex
- W2055818547 via openalex
- W2060863314 via openalex
- W2064273803 via openalex
- W2065018564 via openalex
- W2066442082 via openalex
- W2071813506 via openalex
- W2093966693 via openalex
- W2094077020 via openalex
- W2097233439 via openalex
Cited by (50)
- Advances in Metabolic Syndrome and Endometriosis: Emerging Insights and Therapeutic Horizons 2026
- Biomarkers of endometriosis 2025
- Diagnostic accuracy of non-coding RNA for detecting endometriosis: A systematic review and meta-analysis 2025
- Identifying serum microRNAs as biomarkers for endometriosis in adolescents and young adults 2025
- Functional biomarkers for endometriosis targeting small RNAs in bacterial extracellular vesicles 2025
- Circulating miRNA as diagnostic tools for gynecological diseases and their applications in biosensor development 2025
- Endometriosis in Adolescence: A Narrative Review of the Psychological and Clinical Implications 2025
- <span data-contrast="auto">Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review <span data-ccp-props="{"> 2024
- Circulating microRNAs as Non-Invasive Biomarkers in Endometriosis Diagnosis-A Systematic Review 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis 2024
- MiRNAs related in signaling pathways of women's reproductive diseases: an overview 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis 2024
- Identification of a Serum Exosome-Derived lncRNA‒miRNA‒mRNA ceRNA Network in Patients with Endometriosis 2024
- Association of endometriosis with Sjögren's syndrome: Genetic insights (Review) 2024
- Endometriotic lesions and their recurrence: A Study on the mediators of immunoregulatory (TGF-β/miR-20a) and stemness (NANOG/miR-145) 2024
- Diagnostic value of the combination of circulating serum miRNAs and CA125 in endometriosis 2023
- Altered Differential Expression of Genes and microRNAs Related to Adhesion and Apoptosis Pathways in Patients with Different Phenotypes of Endometriosis 2023
- Genetics and genomics of endometriosis☆ 2023
- The Pathological Role of miRNAs in Endometriosis 2023
- TNFα-Induced Altered miRNA Expression Links to NF-κB Signaling Pathway in Endometriosis 2023
- Circulating miR-3613-5p but not miR-125b-5p, miR-199a-3p, and miR-451a are biomarkers of endometriosis 2023
- Identifying a panel of nine genes as novel specific model in endometriosis noninvasive diagnosis 2023
- Comparative Study of Serum miRNA as A Biomarker for Non-Invasive Diagnosis in Suspected Versus Proven Cases of Endometriosis 2023
- Liquid Biopsy in Endometriosis: A Systematic Review 2023
- Endometriosis-associated infertility: From pathophysiology to tailored treatment 2022
- Expressão diferencial de genes e microRNAs relacionados com as vias de adesão e apoptose nos diferentes fenótipos de pacientes com endometriose 2022
- Endometriosis Research: From Bench to Bedside 2022
- Integrated bioinformatic analysis of dysregulated microRNA-mRNA co-expression network in ovarian endometriosis 2022
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- Roles of microRNAs in Regulating Apoptosis in the Pathogenesis of Endometriosis 2022
- Hsa-mir-135a Shows Potential as A Putative Diagnostic Biomarker in Saliva and Plasma for Endometriosis 2022
- Inflammatory MicroRNAs and the Pathophysiology of Endometriosis and Atherosclerosis: Common Pathways and Future Directions Towards Elucidating the Relationship 2022
- Identification of miR-34-3p as a candidate follicular phase serum marker for endometriosis: a pilot study 2022
- Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer 2022
- MicroRNAs Dysregulation as Potential Biomarkers for Early Diagnosis of Endometriosis 2022
- Ovarian endometriosis, a precursor of ovarian cancer: Histological aspects, gene expression and microRNA alterations (Review) 2021
- Circulating miRNAs Related to Epithelial–Mesenchymal Transitions (EMT) as the New Molecular Markers in Endometriosis 2021
- Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review 2021
- The Role of miRNAs 340‐5p, 92a‐3p, and 381‐3p in Patients with Endometriosis: A Plasma and Mesenchymal Stem‐Like Cell Study 2021
- microRNAs as novel diagnostic biomarkers in endometriosis patients: a systematic review and meta-analysis 2021
- Novel diagnostic options for endometriosis – Based on the glycome and microbiome 2021
- miR-424-5p Combined with miR-17-5p Has High Diagnostic Efficacy for Endometriosis 2021
- Circulating serum miR-200c and miR-34a-5p as diagnostic biomarkers for endometriosis 2021
- A Panel of Plasma miRNAs 199b-3p, 224-5p and Let-7d-3p as Non-Invasive Diagnostic Biomarkers for Endometriosis 2021
- MicroRNA variants in endometriosis and its severity 2021
- Molecular dysregulations underlying the pathogenesis of endometriosis 2021
- A critical appraisal of the circulating levels of differentially expressed microRNA in endometriosis 2021
- microRNA and Overcoming the Challenges of Their Use in the Diagnosis of Endometriosis 2020
- Endometriosis 2020
- Accurate diagnosis of endometriosis using serum microRNAs 2020
Source provenance
- europepmc
- last seen: 2026-08-15T06:15:18.721777+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:58.344756+00:00
License: CC0
· commercial use OK